AfterRaise/Companies/Tenpoint Therapeutics

Tenpoint Therapeutics

Overview

Where Tenpoint Therapeutics is now

Tenpoint Therapeutics announced a Series B round of $235M on 29 January 2026, led by Janus Henderson.

Latest round
Series B
Amount
$235M
Announced
29 January 2026
Headquarters
UK
Sector
Biotech & Pharma
Investors
Janus Henderson
Also participating
existing investors including EQT Life Sciences, Sofinnova Partners, and F-Prime
Relevant leadership
CEO Henric Bjarke and Chairman Dr

Current direction Inferred

What this company is working on

ProductCommercial growth

Read from the company's own description of what the funding supports.

Momentum Inferred

AfterRaise Score

49
Steady growth
0 funding signals in the last 90 days
Funding recency
9/40
announced within the last year
Round scale
22/25
round size relative to the market
Funding stage
18/20
Series B
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 29 January 2026
    $235M Series B
    Led by Janus Henderson.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Tenpoint Therapeutics from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Tenpoint Therapeutics

Not yet specified

Tenpoint Therapeutics has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Tenpoint Therapeutics.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector